Cybersecurity giant Malwarebytes has announced it has received a $100 million cash injection from Vector Capital, a private equity firm that invests in established technology businesses. Vector ...
Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
CHICAGO--(BUSINESS WIRE)--Gene delivery technologies are turning into the next big-ticket item globally, as the most recent investment received by VectorBuilder Inc., a global leader in this field, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results